Logistics & Transportation

Articles

Financial commitment expected to expand the development and commercialization pipeline for new medicines 

Deal is dependent on FDA approval of Phathom’s vonoprazan compound

Five-year, nearly $90 million deal revolves around bulk drug substance formulation for Providence’s future shot

Expansion at German facility features new GMP manufacturing lines and a cleanroom, among other additions 

Latest construction plan continues CDMO’s vision for biopharma expansion 

CDMO’s objective is to cater to various market segments in order to meet microbial bio-manufactured compound demand

After previously going bankrupt, center is now under US ownership for the first time

Swiss organization will take patient-centric approach towards developing injectables

Company’s prospective malaria and tuberculosis doses will be developed in Rwanda, Senegal

Irvine, CA, location will house 40,000 square feet of oral solid dosage forms